Literature DB >> 26223297

Juvenile systemic lupus erythematosus: onset patterns and short-term outcome in Egyptian children, a single-center experience.

M A Abdel-Hafez1, H Abdel-Nabi2.   

Abstract

OBJECTIVE: The objective of this article is to define disease onset pattern and understand the response to therapy in children with systemic lupus erythematosus (SLE) in Egypt.
METHODS: A prospective cohort of 41 Egyptian children diagnosed with SLE was analyzed. SLE Disease Activity Index (SLEDAI) score was used to record disease activity at onset, and renal biopsy was performed to define the stage of lupus nephritis. Response to therapy over a follow-up period ranging from 10 to 50 months was evaluated.
RESULTS: The mean age at diagnosis was 12.12 ± 3.45 years. Thirty-six (87.8%) patients were females. Most patients had multiple manifestations at onset. The most common presenting symptoms were pallor and fever (51.2% and 43.9%, respectively). Lupus nephritis was found in 27 (65.9%) children. International Society of Nephrology (ISN) classes I and III were the most common findings on renal biopsy. Neuropsychiatric manifestations were present at disease onset in 19 patients (46.3%) with a bad prognostic course. At diagnosis, high SLEDAI scores were recorded (mean: 29.95 ± 2.06). The mean renal SLEDAI score was 10.2 ± 4. At follow-up 16 (39.02%) patients were in complete remission, 10 (24.39%) were in partial remission, two (4.87%) had active disease, five (12.9%) had relapsed, four (9.75%) had died and four (9.75%) patients were lost to follow-up.
CONCLUSIONS: Egyptian children with SLE appear to have severe disease on presentation with high SLEDAI scores and high prevalence of lupus nephritis, but respond well to therapy with a favorable short-term prognosis.
© The Author(s) 2015.

Entities:  

Keywords:  Juvenile; SLE; onset pattern; outcome

Mesh:

Year:  2015        PMID: 26223297     DOI: 10.1177/0961203315598016

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  4 in total

1.  Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.

Authors:  L B Lewandowski; L E Schanberg; N Thielman; A Phuti; A A Kalla; I Okpechi; P Nourse; P Gajjar; G Faller; P Ambaram; H Reuter; G Spittal; C Scott
Journal:  Lupus       Date:  2016-08-19       Impact factor: 2.911

2.  Juvenile systemic lupus erythematosus: a single-center experience from southern Turkey.

Authors:  Sibel Balci; Rabia Miray Kisla Ekinci; Aysun Karabay Bayazit; Engin Melek; Dilek Dogruel; Derya Ufuk Altintas; Mustafa Yilmaz
Journal:  Clin Rheumatol       Date:  2019-01-16       Impact factor: 2.980

3.  Serum-soluble CXCL16 in juvenile systemic lupus erythematosus: a promising predictor of disease severity and lupus nephritis.

Authors:  Arwa Mohammad Hassan; Nessma Mohamed Ahmed Farghal; Doaa Salah Hegab; Wesam Salah Mohamed; Hend Hassan Abd-Elnabi
Journal:  Clin Rheumatol       Date:  2018-07-13       Impact factor: 2.980

4.  Autoantibody Profile of Egyptian Juvenile Systemic Lupus Erythematosus Patients and Its Association with Clinical Characteristics and Disease Activity.

Authors:  Mohammed Abd El Monem Teama; Marwa Adham El-Mohamdy; Fatma Abdellah Abdullah Mahmoud; Fatma Mohammed Badr
Journal:  Open Access Rheumatol       Date:  2021-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.